SynopsisPreladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor. The global Preladenant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast .....
SynopsisMonomethyl Fumarate (CAS 2756-87-8), the active metabolite of the psoriasis drug Fumaderm, is a potent GPR109A agonist. The global Monomethyl Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a .....
SynopsisAcebilustat (CAS 943764-99-6), also known as ZK322, is a novel, oral, potent and selective leukotriene A4 hydrolase inhibitor that is a promising new once-daily oral antiinflammatory drug in development for treatment of cystic fibrosis (CF) and other diseases......
SynopsisDithranol (CAS 1143-38-0) is a hepsin activity inhibitor used for treatment of psoriasis. Dithranol exerts a direct effect on keratinocytes and leukocytes. The global Dithranol market was valued at US$ million in 2023 and is anticipated to reach US$ mill.....
SynopsisZalcitabine (CAS 7481-89-2) is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). The global Zalcitabine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast pe.....
SynopsisBiochanin A (CAS 491-80-5) is a nitric oxide synthase inhibitor and apoptosis inducer. The global Biochanin A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024.....
SynopsisSotrastaurin is a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis. The global Sotrastaurin (PKC Inhibitor) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessi.....
SynopsisLoxoprofen sodium (CAS 80382-23-6) is a nonselective inhibitor of COX-1 and COX-2 that exhibits properties typical of most non-steroidal anti-inflammatory drugs (NSAIDs), including anti-inflammatory, analgesic, and antinociceptive activities. The global .....
SynopsisSolasodine is a potentially useful precursor for steroidal compounds and hormones, this is usually found in plants from the solanaceae family. The global Solasodine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,.....
SynopsisOclacitinib is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. The global Oclacitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast.....
